Questions? Give Us a Call
(678) 940-6433

Kymanox New Executive Advisor: Fran DeGrazio

Kymanox New Executive Advisor: Fran DeGrazio

Keep up with the latest from

Fill out the form Below

Kymanox Corporation (“Kymanox”), a professional services provider exclusively serving the Life Science industry, is honored to announce Fran DeGrazio to the newly formed Kymanox Executive Advisors team.  This team of highly distinguished industry executives has led some of the top companies in the biopharma industry, and its members are highly recognized as industry experts.

DeGrazio has over 35 years of experience in technical product development, quality, regulatory, marketing, and business strategy, serving most recently as the Chief Scientific Officer at West Pharmaceutical Services. As an industry leader, she has provided significant expertise in several areas including, but not limited to, the following:

  • Combination product (e.g., biologic + device) development,

  • Quality and regulatory strategy,

  • Primary packaging with special formulations for sensitive biologics, including closures for cryogenic storage used in cell and gene therapies, and

  • Expertise in industry-leading wearable injector platforms.

DeGrazio is a frequent presenter and organizer at industry-leading conferences including the Parenteral Drug Association (PDA) and the former Xavier Health Combinations Summit.  Fran DeGrazio recently received the Edward Smith Packaging Science Award at the 2022 PDA Annual Meeting in Dallas for outstanding lifetime contributions in packaging for the pharmaceutical industry.

Michael Denzer, a key executive at Kymanox, states, “Our mission is to help the industry deliver critical medicines to humanity – quickly and reliably.  Fran brings an incredible wealth of knowledge, expertise, experience, and passion for medicinal product development.  Fran’s guidance will help Kymanox double-down on our mission and assist our clients to speed their Combination Products, including Cell & Gene Therapies, to market.”

“Fran DeGrazio, as our first Kymanox Executive Advisor (KEA), will solidify our strategic professional advisement services and further establish Kymanox as an industry thought leader,” said Stephen M. Perry, CEO and Founder at Kymanox. “Fran is the perfect person to be bestowed the honor as our first KEA member; we look forward to adding to the team in the coming weeks and continuing to advise organizations on their most challenging strategy opportunities.”

DeGrazio holds a degree in Chemistry from Cabrini University.  She is active in PDA and serves on several industry committees throughout the year.

To learn more about how Kymanox can help you with your complex life science engineering challenges, contact us at or visit

About Kymanox:

Kymanox is a life science professional services organization that offers engineering, scientific, compliance, and project management support to companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries.  With its diverse team of experts, Kymanox helps clients navigate commercialization challenges that arise throughout a product’s life cycle – from early development to post-market – with optimized safety, quality, efficacy, and accessibility.  Kymanox was founded in 2004 and is headquartered in Morrisville, North Carolina USA.  For more information, please visit


Read more BELOW


The 2024 virtual Men’s Round Table will be held Q4, 2024, date TBD.

2024 Virtual Men’s Round Tables

2023 Virtual Men’s Round Table was held on November 7th, 2023 via Zoom.


2024 Virtual Women’s Round Table

2023 Women’s Round Table #1 was held on October 20th, 2023 via Zoom


Chicken Salad Chick in unique position to expand

With few other chicken salad restaurants on the market, Chicken Salad Chick describes the business as “a category of one.” Chicken Salad Chick finished last year with 255 locations and expects at least 40 openings in 2024, and it envisions a total addressable market of

See Website for Details

This content (including text, artwork, graphics, photography, and video) was provided by the third party(ies) as referenced above. Any rights or other content questions or inquiries should be directed such third-party provider(s).

Receive the CCR 2024 Idustry Report

Get ahead of your Competitors with CCR's FREE Industry Insider's Report 2024!

Always stay two steps ahead of your Competitors. Stay informed with the latest in the Industry. 

This site uses cookies to ensure that you get the best user experience. By choosing “Accept” you acknowledge this and that operates under the Fair Use Act. Find out more on the Privacy Policy & Terms of Use Page